Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,834
Closed -$237K 782
2026
Q1
$237K Sell
2,834
-2,424
-46% -$233K ﹤0.01% 709
2025
Q4
$488K Sell
5,258
-268
-5% -$29.2K 0.01% 560
2025
Q3
$688K Buy
5,526
+32
+0.6% +$4.07K 0.01% 496
2025
Q2
$723K Buy
5,494
+3,025
+123% +$342K 0.01% 489
2025
Q1
$259K Buy
2,469
+439
+22% +$46K 0.01% 575
2024
Q4
$220K Buy
+2,030
New +$227K 0.01% 593
2017
Q4
Sell
-16,259
Closed -$1.26M 601
2017
Q3
$1.26M Hold
16,259
0.05% 300
2017
Q2
$1.1M Buy
16,259
+542
+3% +$35.5K 0.05% 320
2017
Q1
$954K Buy
+15,717
New +$977K 0.04% 340

Other funds holding ITRI

Hancock Whitney's ITRI Position: Q2 2026 in Review

Hancock Whitney sold out of Itron (ITRI) in Q2 2026, closing a stake of 2,834 shares — an estimated $237K sold.

Hancock Whitney first reported a position in ITRI in Q1 2017 and held it in 9 quarters. The position peaked at $1.26M in Q3 2017. 413 funds tracked by Wall St. Rank hold ITRI as of Q2 2026.

  • Hancock Whitney reported no remaining Itron position as of Q2 2026 after selling out during the quarter.
  • Hancock Whitney sold 2,834 Itron shares in Q2 2026, an estimated $237K.
  • Hancock Whitney first reported a position in Itron in Q1 2017 and held it in 9 quarters.
  • Hancock Whitney's Itron position peaked at $1.26M in Q3 2017.
  • 413 funds tracked by Wall St. Rank held Itron as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.